Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R9UO
|
|||
| Former ID |
DIB015841
|
|||
| Drug Name |
PAN-622
|
|||
| Synonyms |
FB50; Fully human mAb 6-22; PAN-355; Anti-HAAH monoclonal antibodies, Panacea; AAH antibodies (anticancer), Panacea/MIT; Human ultra-affinity antibodies, Panacea/MIT; Human aspartyl (asparaginyl) beta-hydroxylase inhibitors (monoclonal antibodies), MedImmune/Panacea
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Company |
Panacea Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.